SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Nargund G. Time for an ultrasound revolution in reproductive medicine. Ultrasound Obstet Gynecol 2002; 20: 107111.
  • 2
    Lim CP, Hasafa Z, Bhattacharya S, Maheshwari A. Should a hysterosalpingogram be a first-line investigation to diagnose female tubal subfertility in the modern subfertility workup? Hum Reprod 2011; 26: 967971.
  • 3
    Kelly SM, Sladkevicius P, Campbell S, Nargund G. Investigation of the infertile couple: a one-stop ultrasound-based approach. Hum Reprod 2001; 16: 24812484.
  • 4
    Exacoustos C, Zupi E, Carusotti C, Lanzi G, Marconi D, Arduini D. Hysterosalpingo-contrast sonography compared with hysterosalpingography and laparoscopic dye pertubation to evaluate tubal patency. J Am Assoc of Gynecol Laparosc 2003; 10: 2932.
  • 5
    Volpi E, Zuccaio G, Patriarca A, Rustichelli S, Sismondi P. Transvaginal sonographic tubal patency testing using air and saline solution as contrast media in routine infertility clinic setting. Ultrasound Obstet Gynecol 1996; 7: 4348.
  • 6
    Savelli L, Pollastri P, Guerrini M, Villa G, Manuzzi L, Mabrouk M, Rossi S, Seracchioli R. Tolerability, side effects and complications of hysterosalpingocontrast sonography (HyCoSy). Fertil Steril 2009; 92: 14811486.
  • 7
    Spalding H, Martikainen H, Tekay A, Jouppila P. Transvaginal salpingosonography for assessing tubal patency in women previously treated for pelvic inflammatory disease and benign ovarian tumors. Ultrasound Obstet Gynecol 1999; 14: 205209.
  • 8
    Prefumo F, Serafini G, Martinoli C, Gandolfo N, Gandolfo NG, Derchi LE. The sonographic evaluation of tubal patency with stimulated acoustic emission imaging. Ultrasound Obstet Gynecol 2002; 20: 386389.
  • 9
    Dietrich M, Suren A, Hinney B, Osmers R, Kuhn W. Evaluation of tubal patency by HysterocontrastSonography (HyCoSy, Echovist) and its correlation with laparoscopic findings. J Clin Ultrasound 1996; 24: 523527.
  • 10
    Orden MR, Juvenlin JS, Kirkinien PP. Kinetics of a US contrast agent in benign and malignant adnexal tumors. Radiology 2003; 226: 405410.
  • 11
    Marret H, Sauget S, Giraudeau B. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. J Ultrasound Med 2004; 23: 16291639.
  • 12
    Testa AC, Ferrandina G, Fruscella E, Van Holsbeke C, Ferrazzi E, Leone FP, Arduini D, Exacoustos C, Bokor D, Scambia G, Timmerman D. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study. J Ultrasound Med 2005; 24: 12671278.
  • 13
    Testa AC, Timmerman D, Exacoustos C, Fruscella E, Van Holsbeke C, Bokor D, Arduini D, Scambia G, Ferrandina G. The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study. Ultrasound Obstet Gynecol 2007; 29: 512516.
  • 14
    Fleischer AC, Lyshchik A, Jones HW Jr. Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings. J Ultrasound Med 2008; 27: 10111018.
  • 15
    Testa AC, Timmerman D, Van Belle V, Fruscella E, Van Holsbeke C, Savelli L, Ferrazzi E, Leone FP, Marret H, Tranquart F, Exacoustos C, Nazzaro G, Bokor D, Magri F, Van Huffel S, Ferrandina G, Valentin L. Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components. Ultrasound Obstet Gynecol 2009; 34: 699710.
  • 16
    Connor V. Contrast infusion sonography in the post Essure setting. J Minim Invasive Gynecol 2008; 15: 5661.
  • 17
    Exacoustos C, Zupi E, Szabolcs B, Amoroso C, Di Giovanni A, Romanini ME, Arduini D. Contrast tuned imaging and second generation contrast agent SonoVue: a new ultrasound approach to evaluate tubal patency. J Minim Invasive Gynecol 2009; 16: 437444.
  • 18
    Lanzani C, Savasi V, Leone FPG, Ratti M, Ferrazzi E. Two dimensional HyCoSy with contrast tuned imaging technology and a second generation contrast media for the assessment of tubal patency in an infertility program. Fertil Steril 2009; 92: 11581161.
  • 19
    Luciano DE, Exacoustos C, Johns DA, Luciano AA. Can hysterosalpingo-contrast sonography replace hysterosalpingography in confirming tubal blockage after hysteroscopic sterilization and in the evaluation of the uterus and tubes in infertile patients? Am J Obstet Gynecol 2011; 204: 7984.
  • 20
    Exacoustos C, Di Giovanni A, Szabolcs B, Binder-Reisinger H, Gabardi C, Arduini D. Automated sonographic tubal patency evaluation with three-dimensional coded contrast imaging (CCI) during hysterosalpingo-contrast sonography (HyCoSy). Ultrasound Obstet Gynecol 2009; 34: 609612.
  • 21
    Zhou L, Zhang X, Chen X, Liao L, Pan R, Zhou N, Di N. Value of three-dimensional hysterosalpingo-contrast sonography with SonoVue in the assessment of tubal patency. Ultrasound Obstet Gynecol 2012; 40: 9398.
  • 22
    Socolov D, Boian I, Boiculese L, Tamba B, Anghelache-Lupascu I, Socolov R. Comparison of the pain experienced by infertile women undergoing hysterosalpingo contrast sonography or radiographic hysterosalpingography. Int J Gynaecol Obstet 2010; 111: 256259.